RK

Rosana Kapeller-Libermann

Director at Schrödinger

Rosana Kapeller-Libermann is CEO and President of ROME Therapeutics and a Fellow at GV. She brings over 25 years of scientific leadership and entrepreneurial experience to her role.

Prior to co-founding ROME, Rosana was the founding Chief Scientific Officer of Nimbus Therapeutics, where she led the company’s initiative to apply advanced computational technologies to the design and development of novel therapeutics. During her tenure at Nimbus, she assembled a strong scientific team that validated the company’s platform and advanced multiple promising programs. Before Nimbus, Rosana served as VP of Research at Aileron Therapeutics. Early in her career, she worked at Millennium Pharmaceuticals, and consulted for Third Rock Ventures and Atlas Venture.

Rosana is a member of the board of directors of Cedilla Therapeutics and of the Blavatnik fellowship key advisory board. She earned her M.D. from Universidade do Estado do Rio de Janeiro in Brazil and her Ph.D. in Molecular and Cellular Biology from Tufts University.

Timeline

  • Director

    Current role